The DEEP Trial results demonstrate improved quality of life in patients with persistent and long-standing persistent Afib who underwent hybrid ablation and LAA exclusion with an AtriClip® device.
Read the data here: <a href="https://t.co/FkHUl2h6SV" target="_blank">https://t.co/FkHUl2h6SV</a>
<a href="https://twitter.com/hashtag/Epeeps?src=hashtag_click" target="_blank">#Epeeps</a> <a href="https://twitter.com/hashtag/HybridAFTherapy?src=hashtag_click" target="_blank">#HybridAFTherapy</a>
